TCTR20210708001已完成1 期
Efficacy and safety of Andrographis paniculata extract in patients with mild COVID-19: A randomized controlled trial
Thai Traditional Medicine Knowlegde funding0 个研究点目标入组 63 人开始时间: 2021年7月8日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 63
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 60 Years（—）
- 性别
- All
入选标准
- •1) age 18 to 60 years
- •2) diagnosis of SARS-CoV-2 infection by positive rRT-PCR test
- •3) being admitted to hospital within 72 hours of illness
- •4) presence of any signs and symptoms of mild COVID-19 (e.g., fever, cough, sore throat, malaise, headache, and diarrhea)
- •5) not having signs and symptoms of pneumonia or abnormal chest imaging
排除标准
- •1)Patient who be treated with any antiviral drugs i.e. favipiravir, remdesivir, Lopinavir, ritonavir, interferon (b1a), chloroquine or hydroxychloroquine
- •2) History of allergy to A. paniculata
- •3) Pregnancy or during lactation
- •4) Patient who has underlying medical conditions that increase risk of severe COVID-19
- •5) Patient with history of rheumatic heart disease and/or renal dysfunction due to Streptococcus group A
- •6) Patient who be treated with anticoagulants i.e., clopidogrel, warfarin, and aspirin.
研究者
相似试验
招募中
3 期
Efficacy and safety of Andrographis paniculata extract for the treatment of asymptomatic or mild-symptoms COVID-19 patients: A double-blinded, randomized-control trialCOVID-19 patienrs, RT-PCR confirmedCovid-19 treatmentAndrographidis paniculatae extractPneumoniaTCTR20211224002Health System Research Institute736
已完成
3 期
The efficacy and safety of Andrographis paniculata extract for the treatment of acute nonspecific upper respiratory tract infections: a randomized double-blind placebo controlled trialAcute nonspecific upper respiratory tract infections with one or more symptoms such as fever,sore throat,nasal congestion,dry infrequent cough and had modified Centor Score of 2 or less.Andrographis paniculataandrographolideacute nonspecific upper respiratory tract infectionspharyngitiscommon coldTCTR20170329002Department of Thai Traditional and Alternative Medicine829
尚未招募
4 期
A clinical study to understand the combined effects of Andrographis & metformin, in comparison to metformin alone treatment on glycemic control in type 2 diabetes patientsCTRI/2019/11/021977Dr Anand Kumar Maurya
已完成
2 期
Comparison efficacy and safety of Andrographis paniculata extract capsules and placebo in COVID-19 patients: Double blind randomized control trialCOVID-19 patient with asymptomatic and mild symptomatic. Progression score between 0-3. (Green color)COVID-19AndrographolideTCTR20210809004Thammasat university186
已完成
2 期
Efficacy of Andrographis paniculata extract Combined with Favipiravir Treatment to Prevent Disease Progression in mild to moderate COVID-19 Patients: A Double-blind, Randomized, Placebo-Controlled StudyMild to moderate COVID-19andrographolides, COVID-19, SARS-CoV-2, andrographis panniculata, favipiravirTCTR20210609001Chulabhorn Royal Academy146